40
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Modulation of subventricular zone oligodendrogenesis: a role for hemopressin?

      research-article

      Read this article at

          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Neural stem cells (NSCs) from the subventricular zone (SVZ) have been indicated as a source of new oligodendrocytes to use in regenerative medicine for myelin pathologies. Indeed, NSCs are multipotent cells that can self-renew and differentiate into all neural cell types of the central nervous system. In normal conditions, SVZ cells are poorly oligodendrogenic, nevertheless their oligodendrogenic potential is boosted following demyelination. Importantly, progressive restriction into the oligodendrocyte fate is specified by extrinsic and intrinsic factors, endocannabinoids being one of these factors. Although a role for endocannabinoids in oligodendrogenesis has already been foreseen, selective agonists and antagonists of cannabinoids receptors produce severe adverse side effects. Herein, we show that hemopressin (Hp), a modulator of CB1 receptors, increased oligodendroglial differentiation in SVZ neural stem/progenitor cell cultures derived from neonatal mice. The original results presented in this work suggest that Hp and derivates may be of potential interest for the development of future strategies to treat demyelinating diseases.

          Related collections

          Most cited references64

          • Record: found
          • Abstract: not found
          • Article: not found

          Multiple sclerosis--the plaque and its pathogenesis.

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Competing waves of oligodendrocytes in the forebrain and postnatal elimination of an embryonic lineage.

            The developmental origin of oligodendrocyte progenitors (OLPs) in the forebrain has been controversial. We now show, by Cre-lox fate mapping in transgenic mice, that the first OLPs originate in the medial ganglionic eminence (MGE) and anterior entopeduncular area (AEP) in the ventral forebrain. From there, they populate the entire embryonic telencephalon including the cerebral cortex before being joined by a second wave of OLPs from the lateral and/or caudal ganglionic eminences (LGE and CGE). Finally, a third wave arises within the postnatal cortex. When any one population is destroyed at source by the targeted expression of diphtheria toxin, the remaining cells take over and the mice survive and behave normally, with a normal complement of oligodendrocytes and myelin. Thus, functionally redundant populations of OLPs compete for space in the developing brain. Notably, the embryonic MGE- and AEP-derived population is eliminated during postnatal life, raising questions about the nature and purpose of the competition.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Origin of oligodendrocytes in the subventricular zone of the adult brain.

              Glial fibrillary acidic protein (GFAP)-positive astrocytes (type B cells) in the subventricular zone (SVZ) generate large numbers of new neurons in the adult brain. SVZ stem cells can also generate oligodendrocytes in vitro, but it is not known whether these adult primary progenitors generate oligodendrocytes in vivo. Myelin repair and oligodendrocyte formation in the adult brain is instead associated with glial-restricted progenitors cells, known as oligodendrocyte progenitor cells (OPCs). Here we show that type B cells also generate a small number of nonmyelinating NG2-positive OPCs and mature myelinating oligodendrocytes. Some type B cells and a small subpopulation of actively dividing type C (transit-amplifying) cells expressed oligodendrocyte lineage transcription factor 2 (Olig2), suggesting that oligodendrocyte differentiation in the SVZ begins early in the lineage. Olig2-positive, polysialylated neural cell adhesion molecule-positive, PDGF receptor alpha-positive, and beta-tubulin-negative cells originating in the SVZ migrated into corpus callosum, striatum, and fimbria fornix to differentiate into the NG2-positive nonmyelinating and mature myelinating oligodendrocytes. Furthermore, primary clonal cultures of type B cells gave rise to oligodendrocytes alone or oligodendrocytes and neurons. Importantly, the number of oligodendrocytes derived from type B cells in vivo increased fourfold after a demyelinating lesion in corpus callosum, indicating that SVZ astrocytes participate in myelin repair in the adult brain. Our work identifies SVZ type B cells as progenitors of oligodendrocytes in normal and injured adult brain.
                Bookmark

                Author and article information

                Journal
                Front Cell Neurosci
                Front Cell Neurosci
                Front. Cell. Neurosci.
                Frontiers in Cellular Neuroscience
                Frontiers Media S.A.
                1662-5102
                27 February 2014
                2014
                : 8
                : 59
                Affiliations
                [1] 1Center for Neuroscience and Cell Biology of Coimbra, University of Coimbra Coimbra, Portugal
                [2] 2Institute of Pharmacology and Neurosciences, Faculty of Medicine, University of Lisbon Lisboa, Portugal
                [3] 3Unit of Neurosciences, Institute of Molecular Medicine, University of Lisbon Lisboa, Portugal
                [4] 4Institute for Stem Cell Research, Helmholtz Centre Munich, German Research Centre for Environmental Health Neuherberg, Germany
                [5] 5Department of Physiological Genomics, Faculty of Medicine, Ludwig-Maximilians University of Munich Munich, Germany
                [6] 6Health Sciences Research Center, University of Beira Interior Covilhã, Portugal
                [7] 7Neurochemistry Laboratory, Biophysics Institute Carlos Chagas Filho, Federal University of Rio de Janeiro Rio de Janeiro, Brazil
                [8] 8Proteimax Biotecnologia LTDA, São Paulo SP, Brazil
                [9] 9Departamento de Biologia Celular e do Desenvolvimento, Instituto de Ciências Biomédicas São Paulo, Brazil
                [10] 10Center of Investigation in Environment, Genetics and Oncobiology, Institute for Biomedical Imaging and Life Sciences, Faculty of Medicine, University of Coimbra Coimbra, Portugal
                Author notes

                Edited by: Oscar Gonzalez-Perez, Univerisdad de Colima, Mexico

                Reviewed by: Fernando De Castro, Hospital Nacional de Parapléjicos-SESCAM, Spain; Parras M. Carlos, Institut National de la Santé et la Recherche Médicale, France

                *Correspondence: João O. Malva, Center of Investigation in Environment, Genetics and Oncobiology, Institute for Biomedical Imaging and Life Sciences, Faculty of Medicine, University of Coimbra, 3000-548 Coimbra, Portugal e-mail: jomalva@ 123456fmed.uc.pt ; Sara Xapelli, Unit of Neurosciences, Institute of Molecular Medicine, University of Lisbon, 1649-028 Lisboa, Portugal e-mail: sxapelli@ 123456gmail.com
                This article was submitted to the journal Frontiers in Cellular Neuroscience.
                Article
                10.3389/fncel.2014.00059
                3936357
                24578683
                e7c55ccb-7e14-4d81-9d34-4c0718d0a5a1
                Copyright © 2014 Xapelli, Agasse, Grade, Bernardino, Ribeiro, Schitine, Heimann, Ferro, Sebastião, De Melo Reis and Malva.

                This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

                History
                : 15 August 2013
                : 07 February 2014
                Page count
                Figures: 2, Tables: 1, Equations: 0, References: 71, Pages: 9, Words: 0
                Categories
                Neuroscience
                Perspective Article

                Neurosciences
                endocannabinoids,hemopressin,subventricular zone,oligodendrogenesis,myelin pathologies

                Comments

                Comment on this article